Psychotherapy and Psychosomatics 1998; 67: 61-70.

Relationships between Alexithymia,
Emotional Control, and Quality of Life

in Patients with Inflammatory Bowel Disease

Ramiro Verissimo [*], Rui Mota-Cardoso [*], Graeme Taylor [**]

Key Words:
Alexithymia, Emotional control, Quality of life, Inflammatory bowel disease

[*] Medical Psychology, Porto Medical School, Al Hernani Monteiro, 4200-319 Porto, Portugal.
[**]
Department of Psychiatry, University of Toronto and Mount Sinai Hospital, Toronto, Canada.

Address mail to
Prof Doutor Ramiro Verissimo
Psicologia Médica / Faculdade de Medicina do Porto
Al Hernani Monteiro, 4200-319 Porto, Portugal.
Phone: + 351 225 023 963 Fax: + 351 225 088 011
E-mail: [email protected]

Abstract

Background: Although the constructs of alexithymia and emotional control have been associated with physical health, the relationship between these constructs is unclear and their influence on health-related quality of life has not been investigated previously. This study examined the relationships between alexithymia, emotional control, and quality of life in 74 patients with inflammatory bowel disease (IBD). Methods: The subjects completed the 20-item Toronto Alexithymia Scale (TAS-20), the Emotional Expression and Control Scale (EEC), and the Inflammatory Bowel Disease Questionnaire (IBDQ) for assessing quality of life. Results: The TAS-20 correlated negatively and significantly with the IBDQ global score and with subscales assessing bowel symptoms, systemic symptoms, and emotional functioning; the emotional control subscale of the EEC correlated positively and significantly with these measures. Although the TAS-20 correlated significantly and negatively with the emotional control subscale, alexithymia and quality of life scores were unrelated to subscales of the EEC assessing tendencies to either hold emotions in or express emotions outwardly. A hierarchical stepwise multiple regression analysis revealed that alexithymia, and to a lesser extent emotional control, play a role in predicting quality of life in patients with IBD. Conclusions: Alexithymia and emotional control are negatively related constructs and each construct has an independent influence on the subjective health status of patients with IBD.

Introduction

Several emotion-related constructs have been linked with increased health problems including alexithymia, emotional control, inhibition, and the repressive-defensive coping style [1-6]. Although emotional control and inhibition appear to be very similar constructs, clinicians and researchers sometimes fail to recognise subtle differences between them and that they are conceptually distinct from both the alexithymia construct and the repressive coping style [3, 4].

As defined in the literature, the repressive coping style is largely an unconscious process of holding distressing thoughts and feelings out of awareness [4, 7]; inhibition and emotional control refer to conscious processes in which an individual actively restrains or holds back from expressing the emotions he or she is feeling [2, 8, 9]. In contrast to the defensive nature of either unconsciously repressing emotional experience or consciously controlling emotional expression, alexithymia involves a deficit in the mental representation of emotions [1, 10]. Consequently, although alexithymic individuals show a tendency to experience high levels of negative emotion, they have difficulty in identifying and verbally expressing their subjective feelings [1, 11].

Recent studies exploring the relationship between alexithymia and the repressive coping style have demonstrated that these are distinct constructs with repressors (identified by high scores on measures of defensiveness and low scores on measures of trait anxiety) being more like individuals who score low on self-report measures of alexithymia [12, 13]. To date, the only study reporting empirical relationships between alexithymia and inhibition and emotional control was conducted by King, Emmons, and Woodley [4] with a sample of undergraduate students. The students were administered a large number of questionnaires including the Toronto Alexithymia Scale (TAS) [14], the Emotional Control Questionnaire (ECQ), which measures the tendency to inhibit emotional expression [15], and the Rosenbaum Self-Control Schedule (S-CS), which assesses the ability to employ a variety of self-control methods including cognitive control of emotional responses [16]. The results of the study were conflicting; the TAS correlated negatively with the S-CS, but positively with the Emotional Inhibition subscale of the ECQ. In contrast to the TAS and S-CS, however, the Emotional Inhibition scale lacked internal reliability.

While the relationship between alexithymia and emotional control requires further investigation, research is also needed to determine whether there are different ways in which these constructs might influence mental and physical health. There is some evidence, for example, that alexithymic characteristics might influence symptom reporting and treatment-seeking [17-19]. Also, it has been suggested that alexithymia might be an adaptive mechanism that emerges in some individuals to help them cope with the emotional impact of a chronic illness or other specific stressful situations [20, 21]. To date, however, there has been little attempt to examine the influence of alexithymia and emotional control on the subjective health status (quality of life) of patients with chronic medical illnesses.

The aims of the present study were to examine further the relationship between alexithymia and emotional control, and to explore the impact of each of these constructs on the health- related quality of life in patients with inflammatory bowel disease.

Method

Subjects

The subjects comprised 74 patients (26 men and 48 women) with inflammatory bowel disease (IBD) who attended the gastroenterology outpatient clinic at a large metropolitan hospital in Portugal over a one year period between April 1995 and March 1996. Patients were invited to participate in the study if they were the first patient of the day to come to the clinic and had a definite diagnosis of IBD established both clinically and by means of radiological, endoscopic, and/or histologic examination. All subjects were Caucasian, had a minimum of 4 years education, and volunteered to take part in the study. The mean age of the group was 38.1 years (SD = 13.4), and the mean duration of illness was 10.0 years (SD = 7.8). The level of disease activity of the participants was established by the gastroenterologist’s ratings on a five-point scale ranging from 0=very good (inactive) and 1=good (mild), to 2=fair (moderate), 3=poor (severe) and 4=very poor (very severe). The mean activity rating for the group was 1.05 (SD=0.95). According to their IBD activity, patients were taking 5-aminosalicylate – 44(90%) of the CD patients and 23(92%) of the UC patients - alone or in combination with steroid treatment - 24(49%) of the CD patients and 7(28%) of the UC patients). The socioeconomic level of the subjects was determined using an adaptation of the Graffar Index [22] on which scores range from 0 to 25 with higher scores indicating lower socioeconomic level. The mean socioeconomic index for the IBD group was 15.5 (SD = 3.5), which corresponds to Class III in the Hollingshead Index. The mean number of years of education was 7.8 (SD = 4.2).

Of the total IBD group, 49 patients (15 men, 34 women) had a diagnosis of Crohn's disease (CD) and 25 patients (11 men, 14 women) had a diagnosis of ulcerative colitis (UC). The CD subgroup had a mean age of 34.8 years (SD = 12.6), mean education of 8.2 years (SD = 4.2), mean socioeconomic index of 15.4 (SD = 3.6), mean duration of illness of 10.2 years (SD = 8.0) and mean disease activity rating of 1.2 (SD=1.0). The UC subgroup had a mean age of 44.6 years (SD = 12.9), mean education of 7.0 years (SD = 4.0), mean socioeconomic index of 15.5 (SD = 3.3), mean duration of illness of 9.7 years (SD = 7.6) and mean disease activity rating of 0.8 (SD=0.8).

The UC subgroup of patients was found to be significantly older than the CD subgroup (t [73] = 3.15, p < 0.01). However, the two subgroups did not significantly differ in education, socioeconomic level, duration of illness, and disease activity level. A chi-square test revealed no significant difference in the ratio of men to women across the UC and CD subgroups.

Measures

The Twenty-Item Toronto Alexithymia Scale (TAS-20)

This 20 item self-report scale is a revised version of the earlier TAS and has been shown to be a psychometrically sound measure of the alexithymia construct [13, 23]. The English version of the TAS-20 was translated into Portuguese with special care taken to use popular synonyms without losing connative equivalence. This draft translation of the scale was then evaluated in some small pilot studies in which respondents were asked to indicate uncertainties they had about the meaning of any of the items. Based on this feedback, revisions were made to the translation of several items, and the final Portuguese TAS-20 was back-translated by a bilingual colleague who was blind to the original English version of the scale. Comparison of the back-translation with the original English version of the TAS-20 indicated excellent cross-language equivalence of the Portuguese TAS-20. Internal reliability of the translated scale was demonstrated in preliminary testing with samples of college students (alpha coefficient = .76) and general practice patients (alpha coefficient = .87). The alpha coefficient in the present study was .67. Although cutoff scores have been recommended by the developers of the TAS-20, these were not used in the present study as they have not been validated in the Portuguese culture.

The Emotional Expression and Control Scale (EEC)

This is an 18 item scale with a 4-point Likert rating format that was developed by Bleiker et al. [6] to assess how individuals generally act when they are angry, anxious, or depressed. Based in part on Spielberger's State-Trait Anger Expression Inventory [24] and the Courtauld Emotional Control Scale devised by Watson and Greer [11], the EEC yields subscale scores for emotional expression-in (EEI) (e.g., 'When I feel afraid or worried, I hide my worries'), emotional expression-out (EEO) (e.g., 'When I feel unhappy or miserable, I say what I feel'), and emotional control (EC) (e.g., 'When I feel angry or very annoyed, I control my behaviour'). The EEC subscales each contain six items and have demonstrated adequate internal consistency and test-retest reliability [6]. In the present study the alpha coefficients for the subscales ranged from .89 to .93.

The Inflammatory Bowel Disease Questionnaire (IBDQ)

This 32 item questionnaire is now widely used to assess quality of life in patients with IBD [25]. The questionnaire uses a 7-point Likert scale to rate four aspects of health status -- (a) bowel symptoms, (b) systemic systems, (c) emotional functioning, and (d) social functioning. Because of reverse scoring on most of the items, higher scores indicate a better quality of life. Although the IBDQ measures subjective symptoms that do not necessarily reflect disease activity (i.e., the degree of inflammation or pathologic change), the assessment of the patient's perception of illness, functional status, and emotional state, in addition to disease-specific symptoms, provides a more accurate appraisal of health-related quality of life [26]. Previous research with a group of CD patients found that scores on all four parts of the IBDQ improved along with improvement in disease activity ratings in response to treatment with methotrexate [27]. In the present study the internal reliability coefficient alphas were .92 for the IBDQ and ranged from .77 to .87 for the four subscales.

Procedure

Following medical assessment by a gastroenterologist, all subjects completed the IBDQ and TAS-20 under the supervision of a consultation-liaison psychiatrist who also obtained information to establish each subject's socioeconomic index. Because of time constraints, subjects were then given a stamped envelope containing the EEC, which they were asked to complete at home and mail back to the clinic. Of the 74 patients, 62 (84%) spontaneously returned completed questionnaires either by mail or by hand delivery at the time of their next appointment within the following four week period.

Statistical Methods

Because alexithymia and emotional control are dimensional rather than categorical constructs, the relationships among the TAS-20, EEC, and IBDQ were evaluated by means of the Pearson product moment correlation test. A hierarchical, stepwise multiple regression analysis was performed to assess which of the independent variables could predict global IBDQ scores.

Results

Mean scores and standard deviations for all of the measures are shown in Table1 for the total IBD group as well as separately for the UC and CD subgroups. There were no significant differences between the UC and CD subgroups on any of the measures.

Table 1.
Means and standard deviations on the IBDQ, TAS-20, and EEC for the total IBD group
(N = 74) and for the ulcerative colitis (N = 25) and Crohn's disease (N = 49) subgroups

   

Total IBD group
Mean± SD

UC group
Mean± SD

CD group
Mean± SD

IBDQ

       
 

Total

154.2± 37.2

150.2± 41.4

156.2± 35.2

 

Bowel

51.9± 11.8

48.8± 13.1

53.4± 10.9

 

Systemic

20.5± 6.9

21.3± 6.8

20.1± 7.1

 

Emotional

55.6± 14.6

54.1± 16.1

56.3± 13.9

 

Social

26.2± 8.1

26.0± 8.4

26.4± 8.1

TAS-20

 

51.2± 9.7

50.8± 10.8

51.5± 9.3

EEC

       
 

EC

14.0± 4.8

14.7± 5.3

13.7± 4.6

 

EEO

12.5± 4.1

11.7± 3.7

12.9± 4.3

 

EEI

13.2± 4.7

12.1± 5.8

13.7± 4.1

IBD = inflammatory bowel disease; UC = ulcerative colitis; CD = Crohn's disease; IBDQ = Inflammatory Bowel Disease Questionnaire; TAS-20 = Twenty-Item Toronto Alexithymia Scale; EEC = Emotional Expression and Control Scale; EC = Emotional Control; EEO = Emotional Expression-Out; EEI = Emotional Expression-In

Note:
Because of missing data, for the EEC scores N = 62 for the total IBD group, 18 for the UC group, and 44 for the CD group.

For the total IBD group, the TAS-20 was unrelated to age, but correlated negatively and significantly with the number of years of education (r = -0.34, p < 0.05) and positively and significantly with the socioeconomic (Graffar) index (r = 0.28, p < 0.05). Alexithymia scores were not significantly related to the duration of illness or the level of disease activity. The EEC scales and the IBDQ showed no significant relationships with age, education, socioeconomic index, and duration of illness and rating of disease activity.

Table 2.
Correlations between the IBDQ and the measures of alexithymia and emotional expression and control for the inflammatory bowel disease group

IBDQ

TAS-20

EC

EEO

EEI

Total

-0.34**

0.37**

-0.11

0.04

Bowel

-0.28*

0.26*

-0.08

0.03

Systemic

-0.37**

0.42**

-0.05

0.06

Emotional

-0.38**

0.43**

-0.09

-0.04

Social

-0.18

0.18

-0.18

0.13

* p< 0.05  ** p< 0.01

IBDQ = Inflammatory Bowel Disease Questionnaire; TAS-20 = Twenty-Item Toronto Alexithymia Scale; EC = Emotional Control Scale; EEO = Emotional Expression-Out Scale; EEI = Emotional Expression-In Scale

Note:
Because of missing data, N = 62 for correlations between IBDQ and EC, EEO, and EEI.

As shown in Table 2, the TAS-20 correlated negatively and significantly with the total score on the IBDQ and with the scores for bowel symptoms, systemic symptoms, and emotional functioning; there was no significant correlation between the TAS-20 and social functioning. The EC scale correlated positively and significantly with the IBDQ global score and with bowel symptoms, systemic symptoms, and emotional functioning, but the correlation was nonsignificant for social functioning. Correlations between the IBDQ and the EEO and EEI scales of the EEC were all nonsignificant.

Examination of the relationships among the measures of alexithymia and emotional expression and control revealed a significant negative correlation (r = -0.40, p < 0.05) between the TAS-20 and the EC scale, but alexithymia was unrelated to emotional expression-in (r = 0.13) and emotional expression-out (r = -0.17). The EEI scale was negatively correlated with the EEO scale (r = -0.34, p < 0.01), but uncorrelated with the EC scale (r = 0.15). The EEO scale also was uncorrelated with the EC scale (r = -0.10).

A hierarchical, stepwise multiple regression analysis was performed with IBDQ global scores as the dependent variable and education, Graffar Index, TAS-20 scores, and EC scores as predictor variables. EE0 and EEI scores were excluded from the regression model because these variables did not correlate with IBDQ scores; education and socioeconomic index were included in the model because they correlated significantly with TAS-20 scores. In the first step of the analysis, education and Graffar Index were entered as a block and accounted for 2.6% of the variance; however, these variables were nonsignificant predictors. Alexithymia scores and emotional control scores were then entered into the model in a stepwise fashion; alexithymia scores accounted for an additional 12.4% of the variance in predicting quality of life. In the final step of the analysis, emotional control scores (b =0.261) were found to contribute an additional 5.6% of the variance over and beyond the contributions of education (b = -0.073), socioeconomic index (b = -0.094), and alexithymia (b = -0.277) (R2 = .206; F[4,57] = 3.69, p < 0.01).

Discussion

The results of this study demonstrate that alexithymia and emotional control are negatively related constructs and that each construct has an influence on the health-related quality of life in patients with IBD. Patients with a tendency to actively control their emotions subjectively experienced fewer bowel and systemic symptoms, and better emotional functioning, than patients who were less disposed to controlling their reactions when they experience distressing emotions. Patients with high degrees of alexithymia experienced a lower quality of life than patients with low degrees of alexithymia; the high alexithymic patients reported more bowel and systemic symptoms and worse emotional functioning. Alexithymia and emotional control did not influence the patients' social functioning such as attending school, work, or social engagements, and participating in leisure or sports activities. Collectively, the results suggest that IBD patients who are the most aware of their subjective feelings (i.e., least alexithymic), but also exert the greatest control over reacting to their emotional states, enjoy a higher quality of life than IBD patients who have difficulty knowing what they are feeling and are less able to control their reactions when distressing emotions are experienced.

Because of the cross-sectional design of the study, it is not possible to determine whether alexithymia and emotional control are antecedant personality traits or emerge in response to having IBD. Both constructs, however, were unrelated to the duration of illness and the level of disease activity. Previous studies with IBD patients similarly found alexithymia to be unrelated to the duration of illness and the level of disease activity [28, 29]. But even if alexithymia is a secondary phenomenon in some medically ill patients, the finding in the present study that alexithymia is associated with a lower quality of life fails to support Freyberger's [21] view that this construct reflects an adaptive coping response in IBD patients. The findings that alexithymia was associated with less education and lower socioeconomic status are consistent with similar findings from other recent studies [30-32]. In contrast to alexithymia, however, education and socioeconomic status did not emerge as significant predictors of IBDQ global scores in the multiple regression analysis.

The finding of a significant negative correlation between the TAS-20 and the EC scale in the IBD patients is consistent with the negative correlation between the TAS and the S-CS obtained by King et al. [4] in a student sample, but contrasts with the positive correlation these investigators reported between the TAS and the Emotional Inhibition scale of the ECQ. Inspection of the items on the EC scale and the Emotional Inhibition scale, however, suggests that the scales measure somewhat different constructs. Whereas the EC items assess the extent to which individuals report controlling their (verbal as well as nonverbal) behaviour when particular feelings are experienced (anxiety, worry, unhappiness, misery, anger, and annoyance) [6], only one item on the Emotional Inhibition scale [15] refers to the control of feelings; the remaining items (e.g., 'When someone upsets me I try to hide my feelings'; and 'When I get upset, I like to talk to someone about it', which is negatively keyed) resemble the items on the EEI and EEO subscales of the EEC.

As King and her colleagues [4] emphasize, it is clearly important for investigators to recognize distinctions among the various inhibitory constructs and to either employ multiple measures or carefully choose a scale that taps the type of inhibition that corresponds to the researcher's definition of inhibition. Although definitions of emotional control generally include the inhibition of overt expression of emotional experience, the EC subscale of the EEC appears to measure an individual's ability to contain and modulate distressing emotions; this ability includes cognitive processes, but the tendencies to either actively suppress or verbally express one's feelings are assessed by the EEI and EEO subscales respectively, neither of which was associated with quality of life in the present study. Moreover, earlier research has shown that the EC scale correlates strongly with the Rationality subscale of the Rationality/Anti-emotionality Scale, which assesses the extent to which an individual uses reason and logic to manage emotions [6].

Given these measurement considerations, the finding of an inverse correlation between the TAS-20 and the EC scale is consistent both with the theoretical view that alexithymia reflects deficits in the cognitive processing and regulation of emotions [1, 33], and with clinical reports that alexithymic individuals are prone to outbursts of weeping, anger, or rage [34]. Moreover, there is now empirical evidence that alexithymic individuals tend to engage in binge eating, alcohol abuse, or other maladaptive behaviours to regulate affects, in contrast to nonalexithymic individuals, who tend to regulate distressing affects by reflecting on their feelings, talking to close friends, or engaging in constructive activities [35].

Crohn's disease and ulcerative colitis are chronic debilitating diseases that have an adverse impact on patients' lives. The results of this study suggest that the quality of life for some patients might be improved by psychotherapeutic interventions aimed at increasing their awareness of, and ability to identify subjective feelings, and at teaching adaptive strategies for modulating and controlling distressing emotional states.Topo

line

Acknowledgements

We are grateful to Dr. James Parker and Dr. William Lancee for their helpful suggestions concerning the statistical analyses, and we thank Dr. R. Michael Bagby for guidance in the writing of the manuscript.


References

  1. Taylor GJ, Bagby RM, Parker JDA: Disorders of Affect Regulation: Alexithymia in Medical and Psychiatric Illness. Cambridge, Cambridge University Press, 1997.
  2. Berry DS, Pennebaker JW: Nonverbal and verbal emotional expression and health. Psychother Psychosom 1993; 59:11-19.
  3. Bonanno GA, Singer JL: Repressive personality style: Theoretical and methodological implications for health and pathology; in Singer, JL (ed): Repression and Dissociation: Implications for Personality Theory, Psychopathology and Health. Chicago, University of Chicago Press, 1990, pp 435-470.
  4. King LA, Emmons RA, Woodley S. The structure of inhibition: J Res Personality 1992; 26:85-102.
  5. van der Ploeg HM, Kleijn WC, Mook J, van Donge M, Pieters AMJ, Leer JH: Rationality and antiemotionality as a risk factor for cancer: Concept differentiation. J Psychosom Res 1989; 33: 217-225.
  6. Bleiker EMA, van der Ploeg HM, Hendriks JHCL, Leer, JH, Kleijn, WC: Rationality, emotional expression and control: Psychometric characteristics of a questionnaire for research in psycho-oncology. J Psychosom Res 1993; 37:861-872.
  7. Weinberger DA: The construct validity of the repressive coping style; in Singer JL (ed): Repression and Dissociation: Implications for Personality Theory, Psychopathology, and Health. Chicago, University of Chicago Press, 1990, pp 337-386.
  8. Pennebaker JW: Traumatic experience and psychosomatic disease: Exploring the roles of behavioural inhibition, obsession, and confiding. Canad Psychol 1985; 26:82-95.
  9. Watson M, Greer S: Development of a questionnaire measure of emotional control. J Psychosom Res 1983; 27:299-305.
  10. Lane RD, Schwartz GE: Levels of emotional awareness: A cognitive-developmental theory and its application to psychopathology. Am J Psychiat 1987; 144:133-143.
  11. Bagby RM, Taylor GJ, Parker JDA: The Twenty-Item Toronto Alexithymia Scale - II. Convergent, discriminant, and concurrent validity. J Psychosom Res 1994; 38:33-40.
  12. Myers LB: Alexithymia and repression: The role of defensiveness and trait anxiety. Pers Indiv Diff 1995; 19:489-492.
  13. Newton TL, Contrada RJ: Alexithymia and repression: Contrasting emotion-focused coping styles. Psychosom Med 1994; 56: 457-462.
  14. Taylor GJ, Ryan D, Bagby RM: Toward the development of a new self-report alexithymia scale. Psychother Psychosom 1985; 44:191-199.
  15. Roger D, Nesshoever W: The construction and preliminary validation of a scale for measuring emotional control. Pers Indiv Diff 1987; 8:527-534.
  16. Rosenbaum M: A schedule for assessing self-control behaviors. preliminary findings. Behav Ther 1980; 11:109-121.
  17. Joukamaa M, Karlsson H, Sholman B, Lehtinen V: Alexithymia and psychological distress among frequent attendance patients in health care. Psychother Psychosom 1996; 65(4):199-202.
  18. Kauhanen J, Kaplan GA, Cohen RD, Salonen R, Salonen JT: Alexithymia may influence the diagnosis of coronary heart disease. Psychosom Med 1994; 56:237-244.
  19. Lumley MA, Norman S: Alexithymia and health care utilization. Psychosom Med 1996; 58:197-202.
  20. Ahrens S, Deffner G: Empirical study of alexithymia: Methodology and results. Am J Psychother 1986; 40:430-447.
  21. Freyberger H: Supportive psychotherapeutic techniques in primary and secondary alexithymia. Psychother Psychosom 1977; 28:337-342.
  22. Graffar M, Corbier J: Contribucion a l’étude de l’influence des conditions socio-economiques sur la croissance et le développement de l’enfant. Courr CIE 1966; XVI(1):1-25.
  23. Bagby RM, Parker JDA, Taylor GJ: The Twenty-Item Toronto Alexithymia Scale - I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994; 38:23-32.
  24. Spielberger CD: State-Trait Anger Expression Inventory, STAXI, Professional Manual. Odessa, Fl, Psychological Assessment Resources, 1988.
  25. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C: A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterol 1989; 96:804-10.
  26. Drossman DA, Li Z, Leserman J, Patrick DL: Ulcerative colitis and Crohn's disease health status scales for research and clinical practice. J Clin Gastroenterol 1992; 15:104-12.
  27. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G et al: Methotrexate for the treatment of Crohn’s disease. New England Journal of Medicine. 332: 292-297, 1995.
  28. Porcelli P, Zaka S, Leoci C, Centonze S, Taylor GJ: Alexithymia in inflammatory bowel disease: A case-control study. Psychother Psychosom 1995; 64:49-53.
  29. Porcelli P, Leoci C, Guerra V, Taylor GJ, Bagby RM: A longitudinal study of alexithymia and psychological distress in inflammatory bowel disease. J Psychosom Res 1996; 41:569-573.
  30. Joukamaa M, Sohlman B, Lehtinen V: Alexithymia in primary health care patients. J Psychosom Res 1995; 39:833-842.
  31. Pandy R, Mandal MK, Taylor GJ, Parker JDA: Cross-cultural alexithymia: Development and validation of a Hindi translation of the 20-item Toronto Alexithymia Scale. J Clin Psychol 1996; 52:173-176.
  32. Todarello O, Taylor GJ, Parker JDA, Fanelli M: Alexithymia in essential hypertensive and psychiatric outpatients: A comparative study. J Psychosom Res 1995; 39:987-994.
  33. Sifneos P: Affect deficit and alexithymia. New Trends Exper Clin Psychiat 1994; 10:193-195.
  34. Nemiah JC, Freyberger H, Sifneos PE: Alexithymia. A view of the psychosomatic process; in Hill OW (ed): Modern Trends in Psychosomatic Medicine, vol 3. London, Butterworths 1976, pp 430-439.
  35. Schaffer CE: The role of adult attachment in the experience and regulation of affect. Doctoral dissertation, Yale University, 1993.Topo

line